Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
risperidone, Quantity: 2 mg
Medis Pharma Pty Ltd
Risperidone
Tablet, film coated
Excipient Ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; iron oxide red; hypromellose; lactose monohydrate; quinoline yellow; titanium dioxide; macrogol 400
Oral
60 tablets
(S4) Prescription Only Medicine
Risperidone-AS is indicated for the treatment of schizophrenia and related psychoses. Risperidone-AS is indicated for the treatment of behavioural disturbances in dementia. Risperidone-AS is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).
Visual Identification: Orange, film-coated, oblong tablet engraved with "R", a breakline and "2" on one side and a plain face on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-09-26